Arkolith/Insider Trading/OVID/Form 4

Levin Jeremy M

CEO, DirectorOvid Therapeutics Inc. (OVID) · full profile →Form 4 · filed Dec 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Conversion(C)71K——3.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Conversion(C)71—$00
Dec 11, 2025Buy(P)47K——47K
Dec 11, 2025Buy(P)71——71
Dec 11, 2025Buy(P)36K——36K

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001256153-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML